JeffreyMBurnsMD

Neurodegenerative

Jeffrey Burns is the Edward H. Hashinger Professor of Neurology. Dr. Burns is the co-director of the KU Alzheimer's Disease Center and also directs the Frontiers Clinical and Translational Science Unit and the Alzheimer and Memory Clinic

Join to view full profile

Dr. Burns is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Burns' full profile

Already have an account?

Office
3901 Rainbow Blvd
# 4070
Kansas City, KS 66160
Phone+1 913-588-6970

Fax+1 913-588-6965

Education & Training

Washington University in St. Louis School of Medicine2011
University of Virginia Medical CenterResidency, Neurology, 2002
University of Virginia Medical CenterInternship, Internal Medicine, 1998 - 1999
University of Kansas School of MedicineClass of 1998

Certifications & Licensure

KS State Medical License 2004 - 2025
MO State Medical License 2002 - 2025
VA State Medical License 1998 - 2002
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Brain Aging Project--Kansas University Start of enrollment: 2004 Nov 01
Completed
Memory and Insulin in Early Alzheimer's Disease Start of enrollment: 2007 Oct 01
Completed
Phase 1, Phase 2
Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD) Start of enrollment: 2010 May 01
Completed
Not Applicable
Dose Response Study of Aerobic Exercise in Older Adults Start of enrollment: 2010 May 01
Completed
Early Phase 1
Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease Start of enrollment: 2011 Jul 01
Completed
Phase 2
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Start of enrollment: 2014 Jan 08
Completed
Phase 2, Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Alzheimer's Prevention Through Exercise Start of enrollment: 2013 Nov 01
Completed
Not Applicable
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

535 citations
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.
Russell H. Swerdlow, Jeffrey M. Burns, Shaharyar M. Khan
Biochimica Et Biophysica Acta. 2014-08-01
733 citations
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Yasser Iturria-Medina, Roberto C. Sotero, Paule-Joanne Toussaint, José María Mateos-Pérez, Alan C. Evans
Nature Communications. 2016-06-21
19 citations
Cerebral β-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's Disease.
Eric D. Vidoni, Hung-Wen Yeh, Jill K. Morris, Kathy L. Newell, Abdulfattah S. Alqahtani
Neuro-Degenerative Diseases. 2016-01-01

Journal Articles

Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment
Jeffrey M Burns, Keith A Johnson, Reisa A Sperling, Jason Karlawish, JAMA Neurology

Authored Content

Short-Term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive ImpairmentAugust 2020

Press Mentions

KU Alzheimer’s Research Center Study Uses Blood Biomarker Testing for Dementia DiagnosisJune 22nd, 2024
KU Alzheimer’s Disease Research Center Receives $15 Million and Second Renewal as One of 31 Nationally Designated Centers by the National Institute on AgingAugust 31st, 2021
F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate over Whether It WorksJune 7th, 2021
Join now to see all

Grant Support

Aerobic Fitness In Slowing The Progression Of Alzheimer'S DiseaseNational Institute On Aging2010–2012
Dose-Response Study Of Exercise In Older AdultsNational Institute On Aging2009–2011
Energy Metabolism And Brain Changes With Age And Alzheimer'S DiseaseNational Center For Research Resources2009–2010
Alterations In Body Composition Are Associated With Brain Atrophy In MCI And ADNational Center For Research Resources2008–2010
Energy Metabolism And Brain Changes With Age And Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2006–2010
Clinical Trial: Valproate In ADNational Center For Research Resources2009
Clinical Trial: DHA Effect On Alzheimer'SNational Center For Research Resources2009
Alzheimer'S RegistryNational Center For Research Resources2009
Intranasal Insulin In ADNational Center For Research Resources2008–2009
Brain Aging ProjectNational Center For Research Resources2008–2009
ADNINational Center For Research Resources2008–2009
Clinical Trial: Valproate In ADNational Center For Research Resources2008
Clinical Trial: DHA Effect On Alzheimer'SNational Center For Research Resources2008
Longitudial Study Of Cardiorespiratory Fitness In Alzheimer'S DiseaseNational Institute On Aging2007–2008
Modifiers Of Brain Aging And Alzheimer'S DiseaseNational Center For Research Resources2007–2008
Placebo-Controlled Trial Valproate To Attenuate Progression Of Alzheimer'S(Ad)National Center For Research Resources2007
Brain Aging Proj: Energy Metabolism &Brain Changes W/ Age &Alzheimer'S DiseaseNational Center For Research Resources2007
Alzheimer'S Disease Neuroimaging InitiativeNational Center For Research Resources2007
Cardiorespiratory Fitness In Alzheimer'S DiseaseNational Institute On Aging2005–2006

External Links

KU Alzheimer and Memory Programhttp://www.KUAlzheimer.org